Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks

被引:22
|
作者
El-Gamal, Mohamed [1 ,2 ]
Salama, Mohamed [1 ,2 ,3 ]
Collins-Praino, Lyndsey E. [4 ]
Baetu, Irina [4 ]
Fathalla, Ahmed M. [5 ]
Soliman, Amira M. [5 ]
Mohamed, Wael [6 ,7 ]
Moustafa, Ahmed A. [8 ,9 ,10 ]
机构
[1] Mansoura Univ, Toxicol Dept, Fac Med, Mansoura, Egypt
[2] Mansoura Univ, Med Expt Res Ctr MERC, Fac Med, Mansoura, Egypt
[3] Trinity Coll Dublin TCD, Global Brain Hlth Inst GBHI, Dublin, Ireland
[4] Univ Adelaide, Adelaide, SA, Australia
[5] Suez Canal Univ, Dept Pharmacol, Fac Med, Ismailia, Egypt
[6] Menoufia Univ, Clin Pharmacol Dept, Fac Med, Mansoura, Egypt
[7] Int Islamic Univ, Dept Basic Med Sci, Kulliyyah Med, Kuantan, Pahang, Malaysia
[8] Western Sydney Univ, Sch Social Sci & Psychol, Sydney, NSW, Australia
[9] Western Sydney Univ, Marcs Inst Brain & Behav, Sydney, NSW, Australia
[10] Univ Johannesburg, Dept Human Anat & Physiol, Fac Hlth Sci, Johannesburg, South Africa
关键词
Parkinsonian; Toxins; Pesticides; Dopamine; Animal models; Epigenetics;
D O I
10.1007/s12640-021-00356-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by cardinal motor impairments, including akinesia and tremor, as well as by a host of non-motor symptoms, including both autonomic and cognitive dysfunction. PD is associated with a death of nigral dopaminergic neurons, as well as the pathological spread of Lewy bodies, consisting predominantly of the misfolded protein alpha-synuclein. To date, only symptomatic treatments, such as levodopa, are available, and trials aiming to cure the disease, or at least halt its progression, have not been successful. Wong et al. (2019) suggested that the lack of effective therapy against neurodegeneration in PD might be attributed to the fact that the molecular mechanisms standing behind the dopaminergic neuronal vulnerability are still a major scientific challenge. Understanding these molecular mechanisms is critical for developing effective therapy. Thirty-five years ago, Calne and William Langston (1983) raised the question of whether biological or environmental factors precipitate the development of PD. In spite of great advances in technology and medicine, this question still lacks a clear answer. Only 5-15% of PD cases are attributed to a genetic mutation, with the majority of cases classified as idiopathic, which could be linked to exposure to environmental contaminants. Rodent models play a crucial role in understanding the risk factors and pathogenesis of PD. Additionally, well-validated rodent models are critical for driving the preclinical development of clinically translatable treatment options. In this review, we discuss the mechanisms, similarities and differences, as well as advantages and limitations of different neurotoxin-induced rat models of PD. In the second part of this review, we will discuss the potential future of neurotoxin-induced models of PD. Finally, we will briefly demonstrate the crucial role of gene-environment interactions in PD and discuss fusion or dual PD models. We argue that these models have the potential to significantly further our understanding of PD.
引用
收藏
页码:897 / 923
页数:27
相关论文
共 50 条
  • [41] Sleep Alteration in an Environmental Neurotoxin Induced Model of Parkinson's Disease
    不详
    FASEB JOURNAL, 2008, 22
  • [42] Rodent models based on endolysosomal genes involved in Parkinson's disease
    Sanchiz-Calvo, Maria
    Bentea, Eduard
    Baekelandt, Veerle
    CURRENT OPINION IN NEUROBIOLOGY, 2022, 72 : 55 - 62
  • [43] Phosphodiesterase 7 Regulation in Cellular and Rodent Models of Parkinson’s Disease
    Jose A. Morales-Garcia
    Sandra Alonso-Gil
    Ángel Santos
    Ana Perez-Castillo
    Molecular Neurobiology, 2020, 57 : 806 - 822
  • [44] The Effect of Levosimendan on Two Distinct Rodent Models of Parkinson's Disease
    Abuirmaileh, Amjad N.
    Alzoubi, Karem H.
    Rababa'h, Abeer M.
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (11) : 1043 - 1051
  • [45] Phosphodiesterase 7 Regulation in Cellular and Rodent Models of Parkinson's Disease
    Morales-Garcia, Jose A.
    Alonso-Gil, Sandra
    Santos, Angel
    Perez-Castillo, Ana
    MOLECULAR NEUROBIOLOGY, 2020, 57 (02) : 806 - 822
  • [46] Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease
    Imbriani, Paola
    Martella, Giuseppina
    Bonsi, Paola
    Pisani, Antonio
    NEUROBIOLOGY OF DISEASE, 2022, 173
  • [47] Cranial and related sensorimotor impairments in rodent models of Parkinson's disease
    Fleming, Sheila M.
    Schallert, Tim
    Ciucci, Michelle R.
    BEHAVIOURAL BRAIN RESEARCH, 2012, 231 (02) : 317 - 322
  • [48] Construct, Face, and Predictive Validity of Parkinson's Disease Rodent Models
    Guimaraes, Rayanne Poletti
    Resende, Maria Clara Souza
    Tavares, Miguel Mesquita
    de Azevedo, Caio Belardinelli
    Ruiz, Miguel Cesar Merino
    Mortari, Marcia Renata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [49] The Benefits of Humanized Yeast Models to Study Parkinson's Disease
    Franssens, V.
    Bynens, T.
    Van den Brande, J.
    Vandermeeren, K.
    Verduyckt, M.
    Winderickx, J.
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2013, 2013
  • [50] CLOSE ASSOCIATION OF AN ONCONEURAL PROTEIN, CDR2 WITH NEUROTOXIN-INDUCED AND DROSOPHILA PD MODELS
    Lee, J. H.
    Hwang, J. Y.
    Oh, Y. J.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 193 - 193